AAAAAA
Results:
1-13
|
Results: 13
Authors:
Ainsworth, M
Bhamarapravati, N
Batson, A
Bishai, D
Moran-Carpentier, O
Casabona, J
Clemens, J
Collins, C
El Habib, R
Forsythe, S
Goldenthal, K
Kunanusont, C
Longini, IM
Mahoney, R
Mastro, TD
Ndumbe, P
Pallangyo, K
Rowley, J
Sadoff, J
Shin, SI
Pratt, D
Stanton, BF
Suraratdecha, C
Teixeira, PR
van den Bussche, I
Vandermissen, W
Walsh, JA
Whittington, D
Widdus, R
Citation: M. Ainsworth et al., Future access to HIV vaccines - Report from a WHO-UNAIDS Consultation, Geneva, 2-3 October 2000, AIDS, 15(7), 2001, pp. W27-W44
Authors:
O'Neill, PD
Dietz, K
Massad, E
Greenhalgh, D
Nagelkerke, NJD
Critchley, F
Edmunds, WJ
Halloran, ME
Keiding, M
Longini, IM
Yip, PSF
Citation: Pd. O'Neill et al., Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data - Discussion, J ROY STA C, 50, 2001, pp. 283-292
Authors:
Hudgens, MG
Longini, IM
Halloran, ME
Choopanya, K
Vanichseni, S
Kitayaporn, D
Mastro, TD
Mock, PA
Citation: Mg. Hudgens et al., Estimating the transmission probability of human immunodeficiency virus ininjecting drug users in Thailand, J ROY STA C, 50, 2001, pp. 1-14
Authors:
Hudgens, MG
Satten, GA
Longini, IM
Citation: Mg. Hudgens et al., Nonparametric maximum likelihood estimation for competing risks survival data subject to interval censoring and truncation, BIOMETRICS, 57(1), 2001, pp. 74-80
Authors:
Halloran, ME
Longini, IM
Citation: Me. Halloran et Im. Longini, Using validation sets for outcomes and exposure to infection in vaccine field studies, AM J EPIDEM, 154(5), 2001, pp. 391-398
Authors:
Longini, IM
Halloran, ME
Nizam, A
Wolff, M
Mendelman, PM
Fast, PE
Belshe, RB
Citation: Im. Longini et al., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control, VACCINE, 18(18), 2000, pp. 1902-1909
Authors:
Guihenneuc-Jouyaux, C
Richardson, S
Longini, IM
Citation: C. Guihenneuc-jouyaux et al., Modeling markers of disease progression by a hidden Markov process: Application to characterizing CD4 cell decline, BIOMETRICS, 56(3), 2000, pp. 733-741
Authors:
Longini, IM
Sagatelian, K
Rida, WN
Halloran, ME
Citation: Im. Longini et al., Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations. (vol 17, pg 1121, 1998), STAT MED, 18(7), 1999, pp. 890-890
Authors:
Longini, IM
Hudgens, MG
Halloran, ME
Sagatelian, K
Citation: Im. Longini et al., A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines, STAT MED, 18(1), 1999, pp. 53-68
Authors:
Halloran, ME
Longini, IM
Struchiner, CJ
Citation: Me. Halloran et al., Design and interpretation of vaccine field studies, EPIDEMIOL R, 21(1), 1999, pp. 73-88
Authors:
Durham, LK
Halloran, ME
Longini, IM
Manatunga, AK
Citation: Lk. Durham et al., Comparison of two smoothing methods for exploring waning vaccine effects, J ROY STA C, 48, 1999, pp. 395-407
Authors:
Datta, S
Halloran, ME
Longini, IM
Citation: S. Datta et al., Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: Randomization by individual versus household, BIOMETRICS, 55(3), 1999, pp. 792-798
Authors:
Golm, GT
Halloran, ME
Longini, IM
Citation: Gt. Golm et al., Semiparametric methods for multiple exposure mismeasurement and a bivariate outcome in HIV vaccine trials, BIOMETRICS, 55(1), 1999, pp. 94-101
Risultati:
1-13
|